China Money Network
Login
Join

Hotung Group, CDIB Capital Lead $12.5M Series B Round In ACT Genomics

  • May 11, 2016 — 06:44 CST

This Data Is Locked!

This area is available only to Subscribers.

ACT Genomics, a Taiwan-based cancer molecular information company, has raised US$12.5 million series B funding led by Hotung Group and CDIB Capital Management, according to... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: